Try our Advanced Search for more refined results
Intellectual Property UK
-
August 01, 2025
Moderna Fights Off Pfizer Challenge To Surviving mRNA IP
The Court of Appeal ruled Friday that remaining protections underpinning Moderna's mRNA vaccine technology are valid, dismissing Pfizer and BioNTech's bid to nix patent claims left untouched by the High Court.
-
August 01, 2025
Gambling Biz Can't Launch 'Aviator' Game Before IP Trial
A digital gambling game developer on Friday won an injunction in a London court blocking a rival from launching an online game using the disputed "Aviator" branding in the U.K. amid a copyright dispute between the two.
-
August 01, 2025
Toyota Drops UPC Challenge To Telecom Patent
Toyota has withdrawn its attempt to revoke a technology company's communications patent at the Unified Patent Court after the carmaker proved its opponent had not validly opted out of the unitary system.
-
July 31, 2025
Venom Bandmates Bite Each Other In Logo Copyright Clash
The former vocalist of hard rock band Venom convinced a judge Thursday that its guitarist had infringed his copyright for four designs used on album covers — but his bandmate likewise persuaded the court that the singer had infringed his copyright for the group's first logo.
-
July 31, 2025
Asos Clothing TM Trimmed In Fight With Sportswear Maker
British officials have narrowed one of Asos' trademarks after sportswear rival Erreà showed that shoppers might think the online retailer's clothing was part of its own well-known brand for leisurewear.
-
July 31, 2025
Fashion Group Wins Block Of Co.'s 'Twenty Four Seven' TM
European officials sided with global fashion group Twenty Four Seven Fashion Ltd. to reject a business owner's bid to reinstate the trademark "twentyfour seven: Jeans since 1975," ruling that the mark had not been used for more than a decade.
-
July 31, 2025
Microsoft's Software Licensing Is Anticompetitive, CMA Says
Britain's antitrust watchdog is poised to sanction Microsoft after an inquiry criticized the anticompetitive effect of its software licensing practices on the market for cloud computing services on Thursday.
-
July 31, 2025
Uni Academic Can't Get UK Patent For Novel Toothbrush
U.K. officials have brushed off a university academic's quest for a patent over a durable toothbrush with bristles made from a high-tech material called borophene, ruling that his blueprint lacks sufficient detail.
-
July 30, 2025
Discord Must Face German Infringement Claim At UPC
Instant messaging company Discord Inc. has failed to convince a Unified Patent Court judge to throw out a claim that it infringed German patent protections for providing "interactive components to a wireless device."
-
July 30, 2025
German Court Revokes Bayer's Xarelto Patent
A German court has stripped Bayer of its patent over blood-thinning drug Xarelto, marking another loss for the pharma giant after it recently lost its protections over the treatment in the U.K.
-
July 30, 2025
Samsung Dodges UPC Infringement Claim Over Wireless Tech
The Unified Patent Court invalidated a technology research company's wireless network technology patent on Wednesday, handing a win to Samsung Electronics in the infringement case.
-
July 30, 2025
Oppo Hits The Brakes On Renault's 'Reno' TM For Tech
Chinese phone maker Oppo has won its bid to block auto manufacturer Renault SAS from securing a trademark over "Reno" to cover software and other technology in the same realm as its brand of Reno phones in the U.K.
-
July 30, 2025
Musicians Win OK For Mass Claim Over UK Copyright Rules
A London court conditionally agreed on Wednesday to let four performers represent a class of 33,000 musicians in their claim that the U.K. government cost them royalties by failing properly to adopt European Union copyright laws.
-
July 30, 2025
Xanax Maker Partially Blocks Hemp Co.'s 'Canvax' TM
A Viatris unit has convinced European officials to block an Italian hemp producer from stamping the trademark "Canvax" on any products that have medicinal purposes because shoppers might confuse it with "Xanax," its trademarked blockbuster anxiety medication.
-
July 29, 2025
Dutch Rail Tech Firm Says Rival Infringed Patent In UK
A Dutch rail technology company has accused a rival of flouting its patent for a way of shutting down sections of a railway, telling a London court that the firm has supplied Network Rail with devices that infringe its intellectual property.
-
July 29, 2025
Viking River Cruises Has Rival's 'Viking Blood' TM Axed In UK
Viking River Cruises has convinced British officials to nix a distillery's trademark application for "Viking Blood" because the cruise operator had already entered the whisky market with its own namesake brand.
-
July 29, 2025
Jaguar Trumps Card Maker's 'Temple Defenders' TM
Jaguar Land Rover has convinced European officials to block a German trading card company from registering a trademark for "Temple Defenders" after the carmaker argued that the name could cause confusion with its range of luxury Defender off-roaders.
-
July 29, 2025
Tech Pro Says Alleged Software Copying Was 'Obvious' Joke
A payments company's former head of technology has denied copying the company's software to help build a rival platform, telling a London court that his ex-employer has taken a joke about pinching the code "out of context."
-
July 29, 2025
IMDb Can't Block 'DMDb' TM Despite Offering Identical Service
Online movie database IMDb has failed in its bid to nix a rival's "DMDb" trademark after U.K. officials held that users would be able to distinguish between them even though they offer identical services.
-
July 29, 2025
Huawei Fails To Get Patent For Communications Tech At EPO
Huawei has lost its attempt to secure a European patent over a way to optimize communications in a mobile network, failing to convince an appeals board that the technology is new enough to deserve protection.
-
July 28, 2025
Glenmark Can't Start Selling MS Drug Amid Biogen Fight
Glenmark has failed to shake off a sales ban and a $1 million fine over its multiple sclerosis treatment after a Swedish appellate court ruled that it couldn't market the generic version as long as Biogen's patent for its blockbuster drug Tecfidera was still in force.
-
July 28, 2025
Volkswagen Wins TM Row As Rival Drops Camper Van Design
Volkswagen successfully defended its camper van design at the European Union Intellectual Property Office after an events planning company withdrew its application for a logo resembling the distinctive vehicles.
-
July 28, 2025
Skechers Can't Block Rival 'S' TM Over Identical Goods
Skechers has lost its bid to nix a Chinese rival's mark for the letter "S" because European officials found that shoppers would not mix up the signs even though they covered identical clothing and shoe products.
-
July 28, 2025
Smith & Nephew Fails To Restore Wound Therapy Patent
Smith & Nephew PLC has lost its attempt to revive a wound therapy patent, failing to persuade a European appeals panel to overturn a decision to void the British medical tech firm's protections after a challenge from a Swedish rival.
-
July 28, 2025
GSK Asks China's Hengrui To Develop 12 Drugs For $12B
Pharmaceutical giant GSK said Monday that it will pay up to $12 billion for Hengrui Pharma of China to develop up to 12 medicines to add to its respiratory, immunology and oncology pipelines.
Expert Analysis
-
Huawei Case Might Mean UK Forum Sets Global FRAND Rates
The U.K. Supreme Court’s eventual opinion in Unwired Planet v. Huawei will decide whether English courts are a proper forum for determining global fair license terms for standard-essential patents, and there are several reasons to question the English courts' creation of this approach, says Thomas Cotter of the University of Minnesota Law School.
-
Must Inventors Be Humans? An Active Debate Over AI Patents
With the first international patents naming artificially intelligent algorithms as inventors filed this summer, and with the U.S. Patent and Trademark Office’s query into whether inventorship laws and regulations need revising, the debate over AI is testing the boundaries of patent laws in the U.S. and elsewhere, says Christian Mammen of Womble Bond.
-
Henry Schein Case Illuminates Maze Of Arbitrability Questions
While the U.S. Supreme Court’s Henry Schein decision strengthens the enforceability of arbitration provisions, the Fifth Circuit’s ruling on remand concerning arbitrability authority, exemplifies a need for careful drafting of arbitration clauses, say Andrew Behrman and Brandt Thomas Roessler at Baker Botts.
-
Using Global Dossier To Simplify USPTO Disclosure Duty
The U.S. Patent and Trademark Office can make compliance with its duty of disclosure less burdensome by allowing applicants to submit a list of patent families that are believed to have material information and defining electronically available records broadly to include the Global Dossier, whose use the USPTO recently encouraged, says Brian Dorini of InterDigital CE Holdings.
-
The Unique Challenges Of Owning International Cannabis IP
Due to the cost of prosecuting patents and the uncertainty in obtaining and enforcing cannabis patents in foreign jurisdictions, building a global cannabis patent portfolio presents complex strategic questions, says Jayashree Mitra of Zuber Lawler.
-
IP Protection Still Elusive For Data Compilations In US And EU
As businesses continue to increase investment into artificial intelligence systems, questions arise as to whether they can own or legally protect data compiled by those systems. Currently, in the U.S. and EU, obtaining copyright protection for databases is difficult and trade secret protection requires policies and procedures to establish rights, say attorneys at Mayer Brown.
-
Perspectives
Artisanal Miners' Roadblocks To Justice: Is A Path Clearing?
Efforts to give small-scale gold miners, who face displacement, pollution and violence at sites around the world, access to fair and functioning justice systems have met with apathy from politicians and fierce resistance from powerful business lobbies, but there are signs that this may be changing, says Mark Pieth, president of the Basel Institute on Governance.
-
How PTAB Is Applying New Patent Eligibility Guidance
Since the U.S. Patent and Trademark Office released its revised patent eligibility guidance in January, the Patent Trial and Appeal Board has been reversing Section 101 rejections at a higher rate, say Nick Anderson and Braden Katterheinrich of Faegre Baker Daniels.
-
Keys To Successful AI Patents In The US And Europe
Unsurprisingly, the World Intellectual Property Organization recently reported that patent filings for artificial intelligence inventions are increasing rapidly. Stakeholders should be mindful of maintaining quality during this filing surge, says Drew Schulte of Haley Guiliano LLP.
-
9 Ways To Prepare Your IP Rights For Brexit
Those with a European intellectual property portfolio should be considering how Brexit — scheduled for March 29 — will affect EU trademarks and registered community designs, says Paula Jill Krasny of Levenfeld Pearlstein LLC.
-
'Biosimilar V. Biosimilar' Patent Case May Be First Of Many
While the idea of patent disputes between makers of follow-on drugs is nothing new, the complaint recently filed by Coherus against Amgen in Delaware federal court is unique in that it pits one biosimilar developer against another, say attorneys with Goodwin Procter LLP.
-
UK Patent Law: Hot Topics Of 2018 And What's Ahead
English courts have been active in the past year, grappling with patent topics like plausibility and equivalents, and 2019 promises to be another exciting year as English patent lawyers await developments on obviousness, insufficiency and employee inventor compensation, says Jin Ooi of Kirkland & Ellis LLP.
-
Coordinating Patent Strategies Across PTAB And EPO
The positions, arguments and prior art raised in U.S. post-grant proceedings at the Patent Trial and Appeal Board may influence European Patent Office oppositions involving counterpart cases. Understanding the procedural similarities and differences between the two jurisdictions is key, says Drew Schulte of Haley Guiliano LLP.
-
New EU Patent Guidelines May Affect Companies' AI Strategy
As compared to the European Patent Office’s guidelines for artificial intelligence and machine learning — which take effect on Thursday — the U.S. eligibility framework may prove to be more favorable to innovators, say Jennifer Maisel and Eric Blatt of Rothwell Figg Ernst & Manbeck PC.
-
Intellectual Property Caught In US-China Trade Crossfire
Earlier this year, President Donald Trump imposed tariffs on Chinese products as a response to China’s trade practices concerning technology transfer, intellectual property and innovation. The U.S.-Chinese trade war highlights the need to approach investments in China differently, taking a broad view of intellectual assets and looking beyond basic legal protection, says Holly White, a consultant at Rouse & Co.